ArticlePediatric blood & cancer2024

Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.

Erin K Barr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.